Standard BioTools Inc. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-05: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-05: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-05: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-05: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-05 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-05 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-05 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-05 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-05-06 10-Q | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-06 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-06 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-06 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-04-27 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-27 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | Policies and Procedures Related to the Grant of Certain Equity Awards Historically, our Human Capital Committee has granted equity awards to new executive officers upon commencement of their employment and has considered providing additional grants to existing executive officers annually based on ov… | |
| 2026-04-27 DEF 14A | Award Timing Method | 2025-01-01..2025-12-31 | Historically, our Human Capital Committee has granted equity awards to new executive officers upon commencement of their employment and has considered providing additional grants to existing executive officers annually based on overall individual and corporate performance and for retention purposes.… | |
| 2026-04-27 DEF 14A | Award Timing Predetermined | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-27 DEF 14A | Award Timing How MNPI Considered | 2025-01-01..2025-12-31 | Our policy is to not grant stock options or similar awards in anticipation of the release of material non-public information and to not time the release of material non-public information based on equity award grant date, but some option grants may be granted close in time to the release of material… | |
| 2026-04-27 DEF 14A | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | No | |
| 2026-04-27 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2025-01-01..2025-12-31 | No | |
| 2026-04-27 DEF 14A | Pay versus Performance Table | 2025-01-01..2025-12-31 | Pay Versus Performance As required by Item 402(v) of Regulation S-K, we are providing the following table and related disclosures. The information contained in this section shall not be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act. Pay Versus Performanc… | |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: DrEgholm | 2025-01-01..2025-12-31 | $8.82M |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: DrEgholm | 2025-01-01..2025-12-31 | $6.20M |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: MrLinthwaite | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: MrLinthwaite | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: DrEgholm | 2024-01-01..2024-12-31 | $8.34M |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: DrEgholm | 2024-01-01..2024-12-31 | $3.79M |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: MrLinthwaite | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: MrLinthwaite | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: DrEgholm | 2023-01-01..2023-12-31 | $1.93M |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: DrEgholm | 2023-01-01..2023-12-31 | $6.17M |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: MrLinthwaite | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: MrLinthwaite | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: DrEgholm | 2022-01-01..2022-12-31 | $15.90M |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: DrEgholm | 2022-01-01..2022-12-31 | $4.28M |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: MrLinthwaite | 2022-01-01..2022-12-31 | $1.64M |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: MrLinthwaite | 2022-01-01..2022-12-31 | -$3.29M |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: DrEgholm | 2021-01-01..2021-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: DrEgholm | 2021-01-01..2021-12-31 | $0.00 |
| 2026-04-27 DEF 14A | PEO Total Compensation | Individual: MrLinthwaite | 2021-01-01..2021-12-31 | $3.31M |
| 2026-04-27 DEF 14A | PEO Actually Paid Compensation | Individual: MrLinthwaite | 2021-01-01..2021-12-31 | $2.10M |
| 2026-04-27 DEF 14A | Named Executive Officers Footnote | 2025-01-01..2025-12-31 | (1) The dollar amounts reported in columns (b) and (d) represent the amount of total compensation reported for Dr. Egholm (our current PEO) and Mr. Linthwaite (our former PEO) for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Summary Compensation Table” a… | |
| 2026-04-27 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-01-01..2025-12-31 | (2) The dollar amounts reported in columns (c), (e) and (g) represent the compensation actually paid to our current PEO, our former PEO and the average compensation paid to our Non-PEO NEOs in each listed year. The compensation actually paid does not mean our PEOs and Non-PEO NEOs earned or were act… | |
| 2026-04-27 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-01-01..2025-12-31 | (2) The dollar amounts reported in columns (c), (e) and (g) represent the compensation actually paid to our current PEO, our former PEO and the average compensation paid to our Non-PEO NEOs in each listed year. The compensation actually paid does not mean our PEOs and Non-PEO NEOs earned or were act… | |
| 2026-04-27 DEF 14A | Peer Group Issuers Footnote | 2025-01-01..2025-12-31 | (5) The weighted peer group TSR amounts reported in column (i) are weighted according to the respective companies’ stock market capitalization at the beginning of each period for which a return is indicated. The peer group used for this purpose consists of the NASDAQ Biotechnology Index, the same pe… | |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2022-01-01..2022-12-31 | -$15.38M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2023-01-01..2023-12-31 | -$560.42K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2024-01-01..2024-12-31 | -$7.13M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2025-01-01..2025-12-31 | -$7.01M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2021-01-01..2021-12-31 | -$2.68M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$693.35K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$3.27M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$592.21K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$2.24M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$1.79M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: DrEgholm | 2022-01-01..2022-12-31 | $3.76M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: DrEgholm | 2023-01-01..2023-12-31 | $511.79K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: DrEgholm | 2024-01-01..2024-12-31 | $3.87M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: DrEgholm | 2025-01-01..2025-12-31 | $6.28M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2021-01-01..2021-12-31 | $2.60M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $672.56K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $964.66K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $614.23K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $1.53M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $1.60M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: DrEgholm | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: DrEgholm | 2023-01-01..2023-12-31 | $2.86M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: DrEgholm | 2024-01-01..2024-12-31 | -$1.45M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: DrEgholm | 2025-01-01..2025-12-31 | -$1.41M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2021-01-01..2021-12-31 | -$1.03M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2022-01-01..2022-12-31 | -$1.72M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$327.31K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $452.05K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$517.54K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$549.29K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2024-01-01..2024-12-31 | $565.63K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2025-01-01..2025-12-31 | $536.85K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2021-01-01..2021-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $27.45K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $128.58K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $140.04K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2023-01-01..2023-12-31 | $1.43M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2024-01-01..2024-12-31 | -$366.45K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2025-01-01..2025-12-31 | -$1.02M |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2021-01-01..2021-12-31 | -$101.28K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2022-01-01..2022-12-31 | -$408.25K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$31.54K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $239.81K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$53.97K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$326.04K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2024-01-01..2024-12-31 | -$42.99K |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: DrEgholm | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-27 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: MrLinthwaite | 2021-01-01..2021-12-31 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |